Mastek Limited Schedules Q4FY26 Results Announcement and Earnings Conference Call for April 2026

2 min read     Updated on 08 Apr 2026, 01:48 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Mastek Limited has scheduled its Board of Directors meeting for April 17, 2026, to approve Q4FY26 and full year audited financial results for the period ended March 31, 2026. The board will also recommend a final dividend for FY2025-26, subject to shareholder approval. An earnings conference call is planned for April 20, 2026, at 10:00 AM IST, where CEO Umang Nahata and CFO Deepak Kedia will discuss results and business outlook with investors and analysts. The company has implemented trading window restrictions from March 31, 2026, until 48 hours after results publication.

powered bylight_fuzz_icon
37181889

*this image is generated using AI for illustrative purposes only.

Mastek Limited has announced key dates for its Q4FY26 financial results and investor communications, setting the stage for comprehensive disclosure of its annual performance for the financial year ended March 31, 2026.

Board Meeting and Financial Results

The company has scheduled a Board of Directors meeting for Friday, April 17, 2026, in compliance with Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board will consider and approve several important matters during this meeting.

Agenda Item Details
Financial Results Standalone and Consolidated Audited Financial Results under Indian Accounting Standards (IndAS) for FY ended March 31, 2026
Dividend Recommendation Final dividend for Financial Year 2025-26, subject to shareholder approval at 44th Annual General Meeting
Additional Matters Any other business with Chair's permission

Trading Window Restrictions

In accordance with the company's Code of Conduct for Prevention of Insider Trading, Mastek has implemented trading window restrictions for its designated persons. The trading window for the company's equity shares has been closed from March 31, 2026, and will remain closed until 48 hours after the financial results are made public.

Earnings Conference Call Details

Pursuant to Regulation 30 and 46(2) of the SEBI regulations, Mastek will conduct an earnings conference call on Monday, April 20, 2026, to discuss the financial results and business outlook with investors and analysts.

Conference Call Parameter Details
Date April 20, 2026
Time (IST) 10:00 AM – 11:00 AM
Universal Access +91 22 6280 1107 / 7115 8008
USA Toll-Free 1 866 746 2133
UK Toll-Free 0 808 101 1573
Singapore Toll-Free 800 101 2045
Hong Kong Toll-Free 800 964 448

Participants are requested to dial-in 10 minutes before the scheduled time. The company has also provided options for DiamondPass™ access and live audio webcast participation.

Management Representation

The earnings call will be led by key members of Mastek's senior management team:

  • Mr. Umang Nahata - Chief Executive Officer, Mastek Group
  • Mr. Deepak Kedia - Chief Financial Officer, Mastek Group

Company Overview

Mastek is positioned as a trusted AI-first, Digital Engineering & Cloud Transformation Partner with a global presence spanning over 40 countries and a workforce of close to 5,000 employees. The company follows a "Lead with AI" approach, integrating intelligence across its solutions and operations to enable organizations to accelerate transformation through ethical, scalable, and domain-driven AI adoption.

The company maintains strategic partnerships with industry leaders including Oracle, Salesforce, Microsoft, AWS, Snowflake, and Databricks, serving key sectors such as Public Sector, Healthcare, Retail, Manufacturing, Higher Education, and Financial Services. Mastek currently serves over 400 active customers, helping them transform their businesses in the evolving technology landscape.

Historical Stock Returns for Mastek

1 Day5 Days1 Month6 Months1 Year5 Years
-1.50%+5.11%+1.79%-25.14%-25.82%+16.35%

How will Mastek's AI-first strategy impact its competitive positioning and revenue growth trajectory in FY27?

What expansion plans might Mastek announce for its global workforce beyond the current 5,000 employees across 40+ countries?

Will the final dividend recommendation signal a shift in Mastek's capital allocation strategy for future investments?

Mastek Limited Grants 6,00,000 Stock Options to Eligible Employees Under ESOP Plans VI and VII

1 min read     Updated on 01 Apr 2026, 07:35 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Mastek Limited has granted 6,00,000 stock options to eligible employees under ESOP Plans VI and VII, effective April 1, 2026, with an exercise price of Rs. 1,000 per option. The options feature a performance-linked vesting schedule over 3-5 years and can be exercised within 7 years of vesting. Each option converts to one equity share with Rs. 5 face value, subject to meeting performance conditions set by the Nomination and Remuneration Committee.

powered bylight_fuzz_icon
36554728

*this image is generated using AI for illustrative purposes only.

Mastek Limited has announced the grant of 6,00,000 stock options to eligible employees under its Employee Stock Options Plans VI and VII. The Nomination and Remuneration Committee approved this grant pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI (Share Based Employee Benefits) Regulations, 2021.

Grant Details and Pricing

The stock options grant encompasses significant details for employee compensation. The company has structured the offering with specific pricing and share parameters.

Parameter Details
Total Options Granted 6,00,000 (Six Lakhs)
Exercise Price Rs. 1,000 per Option
Face Value per Share Rs. 5
Effective Date April 1, 2026
Applicable Plans ESOP Plan VI and Plan VII

Vesting Schedule and Performance Conditions

The options follow a performance-linked vesting structure spanning multiple years. The vesting schedule allows for up to 100% of the options to vest at the end of the 3rd year from the grant date, subject to achieving performance conditions defined by the Nomination and Remuneration Committee.

If performance conditions are not met at the first vesting date, the balance unvested options will have additional opportunities to vest:

  • Second vesting opportunity: 4th year from grant date
  • Third vesting opportunity: 5th year from grant date
  • Lapse condition: All options remaining unvested after the 3rd vesting date shall lapse

Exercise Period and Regulatory Compliance

The exercise framework provides flexibility for option holders while maintaining regulatory compliance. Once vested, employees have a maximum period of 7 years from the date of vesting to exercise their options.

Compliance Aspect Status
SEBI Regulations Compliance Yes
Share Type Equity shares, fully paid up
Administration Nomination and Remuneration Committee
Regulatory Framework SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021

The stock options are governed under ESOP Plan VI and Plan VII, which are administered and implemented by the company's Nomination and Remuneration Committee. This grant represents part of Mastek's employee retention and incentive strategy, linking employee rewards to company performance through the structured vesting conditions.

Historical Stock Returns for Mastek

1 Day5 Days1 Month6 Months1 Year5 Years
-1.50%+5.11%+1.79%-25.14%-25.82%+16.35%

What specific performance metrics will Mastek use to determine whether employees meet the vesting conditions over the next three years?

How might this significant ESOP grant impact Mastek's earnings per share dilution when employees begin exercising options from 2029 onwards?

Will Mastek need to expand its existing ESOP pool or seek shareholder approval for additional share allocations to accommodate future grants?

More News on Mastek

1 Year Returns:-25.82%